Safety and efficacy of ultralow-dose fluoroscopy in left atrial appendage occlusion
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background Minimizing radiation exposure has become a growing priority in electrophysiology, with increasing adoption of zero- or minimal-fluoroscopy techniques. Little is known about left atrial appendage occlusion (LAAO) using ultra-low-dose fluoroscopy. Objective To assess the safety and efficacy of an ultra-low-dose fluoroscopy strategy for LAAO. Methods In a prospectively maintained registry at our center, 46 patients underwent LAAO with ultra-low-dose fluoroscopy using Watchman FLX devices (Boston Scientific, USA). The ultra-low-dose strategy was a priori planned in these patients with the goal of minimizing radiation exposure (total radiation exposure <10 mGy), while relying on transesophageal echocardiography (TEE) guidance for device placement. The ultra-low-dose fluoroscopy group was compared using propensity score matching to patients treated with standard fluoroscopy guidance (1:3 matching; n=46 vs. 138). Baseline characteristics, procedural metrics, and clinical outcomes were compared between groups. Results Procedural success was 100% in both groups, with significantly shorter procedural duration in the ultra-low-dose group (42 vs. 60 minutes, p<0.001). Periprocedural adverse events were infrequent and did not differ significantly (none in ultra-low-dose vs. three cases (2.2%) in standard-dose, p=0.6). Closure success at 45 days was high in both groups (97.8% vs. 100%, p=0.3). Device-related thrombus occurred in one ultra-low-dose patient (2.2%) – with none in the standard group (p=0.3) – and resolved without sequelae with anticoagulation. The one-year rate of ischemic stroke or systemic embolism was similarly low between groups, with two (4.3%) vs. three (2.2%) events, respectively (p=0.4). Conclusion Ultra-low-dose fluoroscopy is a safe and effective, radiation-sparing strategy for LAAO.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Safety and efficacy of ultralow-dose fluoroscopy in left atrial appendage occlusion
- Date Crossref
- 01/05/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.